{"podcast":{"title":"Answers from the Lab","slug":"answers-from-the-lab-870296","podcast_index_feed_id":870296,"rss_url":"https://feeds.transistor.fm/answers-from-the-lab","website_url":"https://news.mayocliniclabs.com/podcast/answers-from-the-lab/","image_url":"https://img.transistorcdn.com/B9HbHcxSMFuy8GSjzQspBU_yr7OZ0kDg-c2slusbf14/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjNj/ZDc0NTE0MWNlOWRl/YzRiN2Q3NDg2Mjg5/YWE4MS5qcGc.jpg","author":"Mayo Clinic Laboratories","episode_count":383,"summary":"A Mayo Clinic curated podcast sharing Mayo Clinic knowledge and advancements on the state of testing, science, and people who are making it happen behind the scenes.","last_synced_at":"2026-06-11T16:18:30.710370+00:00","page_url":"https://stenobird.com/podcast/answers-from-the-lab-870296"},"episode":{"title":"Preeclampsia Test Helps Extend Pregnancy to Improve Outcomes","slug":"preeclampsia-test-helps-extend-pregnancy-to-improve-outcomes","published_at":"2026-03-19T06:00:00+00:00","page_url":"https://stenobird.com/podcast/answers-from-the-lab-870296/preeclampsia-test-helps-extend-pregnancy-to-improve-outcomes","show_page_url":"https://stenobird.com/podcast/answers-from-the-lab-870296","url":"https://share.transistor.fm/s/6a4a6aa5","audio_url":"https://media.transistor.fm/6a4a6aa5/00d7baa5.mp3","summary":"In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D. , president and CEO of Mayo Clinic Laboratories, to share industry updates and Mayo Clinic’s test development success in 2025. Later, Dr. Pritt welcomes Janelle Santos, M.D. , a maternal-fetal medicine specialist at Mayo Clinic, to discuss how she uses a preeclampsia test to care for her patients. Public policy insights for 2026 (00:34): Dr. Bill Morice shares insights on reimbursement and AI-related policy developments following an association meeting in Washington, D.C. An unprecedented year for test development (04:45) : Discover how Mayo Clinic’s record year for test development delivers value to Mayo Clinic’s patients and Mayo Clinic Laboratories’ clients. Novel preeclampsia testing (08:13) : Learn how new clinical testing helps physicians improve outcomes for women at risk for preeclampsia and their babies. Note: Information in this post was accurate at the time of its posting. Resources 4 steps to establishing a new approach to innovation Innovation beyond the bench: Translating science into better diagnostics and outcomes Preeclampsia: Empowering confident decision-making through preeclampsia risk assessment Assay stratifies pregnant women's preeclampsia risk: Joshua Bornhorst, Ph.D. Preeclampsia sFlt-1/PIGF Ratio, Serum (Mayo ID: PERA)","meta_description":"In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Mor…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1053,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/answers-from-the-lab-870296/episodes/preeclampsia-test-helps-extend-pregnancy-to-improve-outcomes/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/answers-from-the-lab-870296/preeclampsia-test-helps-extend-pregnancy-to-improve-outcomes.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}